DOHENY ASSET MANAGEMENT /CA - FATE THERAPEUTICS INC ownership

FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 235 filers reported holding FATE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.88 and the average weighting 0.3%.

Quarter-by-quarter ownership
DOHENY ASSET MANAGEMENT /CA ownership history of FATE THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$224,000
-33.7%
5,7800.0%0.16%
-31.2%
Q4 2021$338,000
-8.4%
5,780
-7.2%
0.24%
-10.2%
Q3 2021$369,000
-36.5%
6,230
-7.0%
0.26%
-29.4%
Q2 2021$581,000
+5.3%
6,7000.0%0.37%0.0%
Q1 2021$552,000
-22.7%
6,700
-14.6%
0.37%
-24.6%
Q4 2020$714,000
+132.6%
7,850
+2.3%
0.50%
+95.3%
Q3 2020$307,000
+16.7%
7,6700.0%0.25%
+2.0%
Q2 2020$263,000
-44.5%
7,670
-68.3%
0.25%
-33.8%
Q1 2020$474,0000.0%24,2000.0%0.38%0.0%
Q4 2019$474,000
+25.7%
24,200
-0.2%
0.38%
+15.0%
Q3 2019$377,000
-32.6%
24,250
-12.0%
0.33%
-30.1%
Q2 2019$559,000
+16.0%
27,550
+0.4%
0.47%
+14.1%
Q1 2019$482,000
+3.7%
27,450
-24.3%
0.41%
+20.6%
Q4 2018$465,000
-10.6%
36,260
+13.5%
0.34%
+25.0%
Q3 2018$520,000
+54.8%
31,935
+7.8%
0.27%
+49.5%
Q2 2018$336,000
+16.7%
29,635
+0.5%
0.18%
+20.5%
Q1 2018$288,000
+234.9%
29,490
+110.6%
0.15%
+277.5%
Q4 2017$86,00014,0000.04%
Other shareholders
FATE THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
JOHNSON & JOHNSON 3,379,064$34,0959.92%
Redmile Group, LLC 12,957,222$130,738,3705.35%
GCM Grosvenor Holdings, LLC 1,037,256$10,465,9132.67%
Casdin Capital, LLC 2,050,000$20,684,5001.60%
DAFNA Capital Management LLC 550,940$5,558,9851.57%
Artal Group S.A. 2,600,000$26,2341.46%
Monaco Asset Management SAM 250,000$2,522,5000.76%
Parametrica Management Ltd 32,254$325,4430.67%
Boxer Capital, LLC 1,250,000$12,612,5000.66%
Bellevue Group AG 4,861,279$49,050,3050.65%
View complete list of FATE THERAPEUTICS INC shareholders